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The stem cell microenvironment is involved in regulating the fate of the stem cell with respect to self-renewal, quiescence,
and diﬀerentiation. Mathematical models are helpful in understanding how key pathways regulate the dynamics of stem cell
maintenance and homeostasis. This tight regulation and maintenance of stem cell number is thought to break down during
carcinogenesis. As a result, the stem cell niche has become a novel target of cancer therapeutics. Developing a quantitative
understanding of the regulatory pathways that guide stem cell behavior will be vital to understanding how these systems change
under conditions of stress, inﬂammation, and cancer initiation. Predictions from mathematical modeling can be used as a clinical
tool to guide therapy design. We present a survey of mathematical models used to study stem cell population dynamics and
stem cell niche regulation, both in the hematopoietic system and other tissues. Highlighting the quantitative aspects of stem cell
biology, we describe compelling questions that can be addressed with modeling. Finally, we discuss experimental systems, most
notably Drosophila, that can best be used to validate mathematical predictions.
1.Introduction
The hematopoietic stem cell niche is an important regulator
of stem cell fate. There are complex signaling pathways,
such as Notch, Wnt, and Hedgehog, that carefully regulate
stem cell renewal, diﬀerentiation, and quiescence [1–3].
Mathematical models can be useful in studying the dynamics
of stem cell maintenance. Quantitative models can provide
information about cell population dynamics, regulatory
feedback of interacting networks, and spatial considerations
related to the structural relationships between stem cells and
their progeny with cells of the microenvironment.
Errors in stem cell division rate or in the balance be-
tween self-renewal and diﬀerentiation may result in tissue
overgrowth or depletion [4]. One novel target of cancer
therapeutics is the stem cell niche [5, 6]. Stem cell niche
signalinginhibitorsarebeingdesignedwiththeideathatreg-
ulatory signals that are active in stem cell niche homeostasis
maygoawryduringcarcinogenesis[6–8].Understandingthe
biology and dynamics of stem cell behavior under normal
conditions and examining how the dynamics change under
conditions of stress is essential to our understanding of how
these mechanisms might change during carcinogenesis.
Mathematical and physical models have been used to
study stem cell population dynamics and the regulation of
stem cell fate through niche signaling with great success. We
presentareviewofquantitativeapproachestounderstanding
stem cell niche signaling in the hematopoietic system, as
well as in other tissues under conditions of homeostasis
and carcinogenesis. We explain the beneﬁts of mathematical
models in advancing our understanding of the mechanisms
ofregulationofstemcellfateandhowthisregulationchanges
in cancer development. We describe models that incorporate
spatial aspects of the regulation of asymmetric division and
compare normal conditions to carcinogenesis. We highlight
the synergistic relationship between mathematical predic-
tionsandexperimentalvalidationandillustrateDrosophilaas
amodel systemforquantitative studies ofthestemcellniche.
Finally, we address the potential for mathematical models to
predict and optimize therapies targeting the stem cell niche.2 Stem Cells International
2.QuantitativeAspectsoftheHematopoietic
Stem Cell Niche
Hematopoietic stem cells (HSCs) are a dynamically well
characterized stem cell population. The hematopoietic sys-
tem was the ﬁrst system in which multipotency, or the
ability for a single HSC to regenerate all of the diﬀerent cell
types within the tissue, was described. A second deﬁning
characteristic for stem cells, self-renewal, has also been
demonstrated in HSCs. Self-renewal is the ability of the
HSC to generate a genetically identical copy of itself during
cell division. This can occur asymmetrically, giving rise to
one identical copy and one partially diﬀerentiated daughter
cell, or symmetrically, giving rise to two identical copies of
itself. Single HSCs have been shown to be self-renewing,
multipotent, and to cycle with slow kinetics. Extrapolation
from feline and murine data suggests a symmetric birth rate
for human HSCs of once every 42 weeks [9]. Quiescence,
the state of not dividing, allows HSCs to avoid mutation
accumulation and contributes to their long lifespan. In
contrast to senescence, where the cell loses its ability to
undergo division, a cell can reawaken from the state of
quiescence to an activated state where it can again undergo
self-renewal.
The stem cell microenvironment regulates stem cell self-
renewal, diﬀerentiation, quiescence, and activation. While
little in situ information is known about the anatomy
and structural relationships of the hematopoietic stem cell
and its niche, there is a growing amount of experimental
information about the behavior of signaling systems that
govern HSC fate.
Population dynamics models have been successfully
used to model the human hematopoietic system in both
healthand disease [9–17].Using stochastic anddeterministic
models,signiﬁcantprogresshasbeenmadeinunderstanding
the dynamics of cancer initiation and progression [18, 19]
and the sequential order of mutation accumulation [20].
Mathematical models have also been useful in modeling
leukemic stem cell and progenitor population changes in
response to therapy and the development of resistance [14].
An ongoing debate in hematopoietic stem cell biology
concerns how much variability exists in hematopoietic stem
cell fate [21]. Stochastic models have been used to study the
dynamics of clonal repopulation [22] following hematopoi-
etic stem cell transplant. In these models, trajectories of
hematopoietic stem cell counts as well as progenitor and
diﬀerentiated cell counts are generated and compared with
observed cell counts. Rates of self-renewal, diﬀerentiation,
and elimination of cells are estimated. Stochastic trajectories
are found to match experimental results. These models
predict that hematopoiesis is probabilistic in nature and
that clonal dominance can occur by chance. These models
could be enhanced by examining regulators of stem cell
fate by the microenvironment. Stochastic simulation can be
used to incorporate elements of the stem cell niche, such as
surroundingstromalcellsandsignalingpathways,andmodel
cell-cell and cell-environment interactions. These models
could identify regulators of stem cell fate and explore the
dynamics of this regulation.
Chronic myelogenous leukemia (CML) represents a nice
system to quantitatively study hematopoietic stem cell and
progenitordynamics.CMListheﬁrstmalignancyrecognized
as a stem cell disorder. The translocation t(9;22) is present
in leukemic stem cells, multipotent progenitors, and their
progeny of the myeloid lineage. This translocation leads to
transcription of the BCR-ABL fusion oncogene which is
thought to regulate cell survival. Therapy inhibiting BCR-
ABL is one of the ﬁrst examples where chronic administra-
tion of a molecularly targeted therapy has led to a dramatic
clinical response. This response is observed in all phases of
the disease.
Mathematical models have been used to demonstrate
that leukemic stem cells are not targeted by imatinib therapy
[14], and that successful therapy must target leukemic stem
cells [12]. Other models have highlighted the importance
of leukemic stem cell quiescence as a mechanism leading to
therapeutic resistance [13].
In a study of chronic myelogenous leukemia under
targeted therapy, Michor et al. [14] describe the dynamics
of leukemic stem cells and the development of resistance
using a Moran process model. Based on calculated rates of
death and diﬀerentiation using data of biphasic decline of
BCR-ABL transcripts, they conclude that the leukemic stem
cell compartment is not sensitive to therapy. An alternative
explanation is provided by Komarova and Wodarz [13],
using a stochastic model in which quiescence and reactiva-
tion of leukemic stem cells are considered. In this work, the
biphasic decline of BCR-ABL transcripts is explained by the
elimination of active leukemic stem cells, followed by the
slowereliminationofquiescentleukemicstemcellsfollowing
their reactivation. This study oﬀers hope that targeted ther-
apy,usedincombinationwithpotentialtherapiesthatleadto
activationofquiescentcells,coulderadicatethestemcell-like
compartment of a tumor. These models could be expanded
by modeling the contribution of the microenvironment that
regulates quiescence and activation of stem cells. Validation
of these models will require experimental determination
of rates of quiescence and reactivation to obtain accurate
parameters for modeling.
Birth-death process models have been used to study
extinction of leukemic and normal hematopoietic stem cells
under therapy targeting leukemic stem cells. These models
conclude that the killing eﬃciency of a therapy is a major
determinant of the mean time to extinction of leukemic stem
cells (optimal duration), while the selectivity of a therapy
predicts the average number of normal hematopoietic stem
cells at the time of leukemic stem cell extinction (safety)
[23]. Incorporating quiescence in these models reveals that
a successful therapy needs to target both active and quiescent
leukemic stem cells.
We extended this model to consider combination of
therapy targeting leukemic stem cells, and their niche was
considered using stochastic simulation. Because stem cell
self-renewal is expected to decrease with Wnt-inhibitor
therapy, we modeled the addition of niche-targeted therapy
as a decrease in birth rates of leukemic stem cells. We
found that this combination can be eﬀective in eliminating
the leukemic stem cell compartment, even when the eﬀectsStem Cells International 3
of BCR-ABL-targeted therapy on stem cells are modest.
We anticipate that extension of these models to include
regulatory feedback of the stem cell microenvironment using
stochastic reaction kinetic methods would be very helpful in
modeling dynamics of niche-targeted therapies.
The hematopoietic stem cell niche has been studied
in the healthy hematopoietic system. A model based on
self-organizing principles demonstrates the importance of
asymmetry in determining stem cell fate and concludes that
stem cell fate is only predictable in describing populations
ratherthanindividualcellularfates[24].Deterministicmod-
els are useful in simulating proliferation and diﬀerentiation
of all populations comprising the stem cell niche [25].
These studies conclude that kinetics are highly variable
because of the relatively small number of cells proliferating
and diﬀerentiating in the niche. Experimental studies have
examined the role of Wnt signaling in regulation of normal
hematopoieticregeneration[26].Weexpectthecombination
of mathematical modeling with experimental validation
to prove useful in modeling the pathways under normal
conditionsanddysregulationofthesepathwaysduringstress,
inﬂammation, and carcinogenesis.
Figure 1 describes the elements of the HSC niche and an
accompanying schematic representation of a mathematical
model of the niche. The model captures the key regulatory
components of niche dynamics, including cell population
sizes and the signaling pathways that regulate them.
3.Drosophila asaClassicModel System
Drosophila represents an excellent model system to study
stem cells, their microenvironment, and the tight regulation
of homeostasis through diﬀerent signaling pathways. The
male Drosophila germ line population is a classic system used
to study properties of the stem cell niche [27, 28]. The power
of this model includes the ability to quantify cell populations
over time, the relatively quick repletion of lost cells with
newly diﬀerentiated cells, and the ability to experimentally
observe spatial eﬀects. These quantitative aspects, as well as
its simple, well-characterized lineages, make the Drosophila
experimental system ideally suited for the development and
validation of mathematical modeling. Finally, vertebrate and
invertebrate digestive systems show extensive similarities in
their developments, cellular makeup, and genetic control
[29].
Mathematical and physical models have been used to
study regulation of stem cell fate through niche signaling
in the Drosophila blood and midgut [30], as well as in the
Drosophila eye [31] and the Drosophila embryo [32], with
great success. Studies of the stem cell niche in model systems
such as Drosophila have revealed adhesive interactions, cell
cycle modiﬁcations, and intercellular signals that operate
to control stem cell behavior [4, 33]. These interactions
have been studied quantitatively. For example, Wnt and
Notch play pivotal roles in stem cell regulation in the
Drosophila intestine [30, 34]. In addition, the APC gene
has been shown to regulate Drosophila intestinal stem cell
proliferation[35].APCiswellknowntoplayaroleinhuman
colon carcinogenesis, and mathematical models have shown
that stem cell proliferation leads to colon tumor formation
in humans [36, 37].
The spatially patterned self-renewal and diﬀerentiation
of stem cells has been extensively studied in Drosophila
embryonic studies of development [32, 38–40]. The spatial
orientation of stem cells has been visualized in Drosophila
brain and testes and has recently been shown to be of
g r e a ti m p o r t a n c ei ne x p e r i m e n t a lm o d e l so fn e u r o b l a s t o m a
growth in Drosophila [41]. We anticipate that the combina-
tion of spatial eﬀects simulation and direct visualization of
the Drosophila midgut through experiment will advance our
understanding of the interaction of alterations in signaling
pathways and spatial eﬀects in carcinogenesis.
4. Extensionto Inﬂammation and
CarcinogenesisacrossTissues
Unifying features of stem cell niche regulation are observed
across tissues and across organisms [42, 43]. Figures 1, 2,
and 3 compare the structural and signaling elements of
the stem cell niche across the hematopoietic, intestine, and
breast tissues. While little is known about the structural
orientation of the human hematopoietic stem cell niche 1,
much has been learned about the signaling pathways in both
the bone and vasculature that regulate HSC fate. Osteoblasts
(OBs) express osteopontin which negatively regulates HSC
proliferation. Tie2/angiopoietin signaling regulates HSC
anchorage and quiescence, and adherence to osteoblasts.
HSCs and OBs are increased via the parathyroid hormone-
related protein receptor (PPR) expressed in OBs. OBs
express N-cadherin which forms a beta-catenin adherens
complex with HSCs. C-myc negatively regulates N-cadherin
in diﬀerentiating HSCs and promotes diﬀerentiation and
displacement from the endosteum. OBs express Jagged-1,
a Notch receptor that when bound inhibits diﬀerentiation
that usually accompanies Wnt-induced HSC proliferation.
GSK-3 activity enhances HSC progenitor activity and may
control asymmetric cell division by modulating Notch and
Wnt signaling pathways.
Figure 2 depicts the intestinal stem cell niche of Dro-
sophila. Here, we see four key cellular populations: intestinal
stem cells (ISCs), enteroblasts (EBs), enterocytes (ECs), and
enteroendocrine(EE)cells.Ithasbeenpreviouslyestablished
that ISCs can self-renew under the inﬂuence of the Wnt
signaling pathway [44] and can asymmetrically divide giving
rise to one partially diﬀerentiated EB cell and one ISC,
under the inﬂuence of the Delta/Notch signaling pathway.
EBs can then diﬀerentiate into either EC cells or EE cells.
There is feedback from the EB population to the ISC
population, which inhibits self-renewal and diﬀerentiation,
in order to maintain stable population sizes under the
normal conditions of homeostasis [45]. The EC population
also interacts with the ISC population via Jak/Stat signaling
feedback, which increases self-renewal and diﬀerentiation, in
conditions when EC loss occurs [45].
Finally,bothstructuralandsignalingaspectsofthebreast
stem cell niche are shown in Figure 3. The hedgehog (Hh)
pathway is required for normal development of the mam-
mary gland and regulates self-renewal of human mammary4 Stem Cells International
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Figure 1: Quantitative aspects of the hematopoietic stem cell (HSC) niche. The left panel provides a structural picture of the niche, while
the right panel shows a schematic representation of a mathematical model for the regulation of hematopoietic stem cell fate. The model
incorporatespopulationcountsandsignalingpathwaysthatmayplayaroleinregulatingstemcellpopulationdynamics.Cellularpopulations
comprising the bone and vascular niches include osteoblasts (OBs), endothelial cells, HSCs, multipotent progenitors (MPPs), common
myeloid progenitors (CMPs), common lymphoid progenitors(CLPs), and diﬀerentiated cells. Signaling from Wnt, β-catenin, p21, p18, and
bmi-1 regulate self-renewal, while Notch and GSK3 feedback from progenitors inhibit diﬀerentiation that usually accompanies self-renewal.
Signaling from osteoblasts includes osteopontin (Opn) expression that inhibits HSC self-renewal, parathyroid hormone-related protein
(PPR) which increases HSCs, N-cadherin which binds β-catenin, and Tie2/angiopoietin which regulates quiescence.Stem Cells International 5
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Figure 2: Structural and dynamic aspects of the Drosophila in-
testinal stem cell (ISC) niche. The left panel shows a structural
picture of the Drosophila intestine, while the right panel reveals
population and regulatory elements of a mathematical model for
ISC regulation. Populations of the intestinal stem cell niche in
the Drosophila include ISCs, enteroblasts (EBs), enteroendocrine
cells (EE), and enterocytes (ECs). Wnt signaling from underlying
smooth muscle and Notch feedback from EB regulate ISC self-
renewal, while Jak/Stat feedback from damaged ECs increases ISC
self-renewal.
stem cells (MSCs) [46–48]. Hh also targets endothelial cells
and induces angiogenesis by promoting endothelial progen-
itor proliferation and migration. Wnt signaling regulates
proliferation, apoptosis, and diﬀerentiation and maintains
stem cells in a self-renewing state. Notch promotes self-
renewal in normal mammary stem cells [46, 49]. Notch3 is
expressed in epithelial progenitors, and Notch4 is expressed
in bipotent progenitors. Markers of mammary stem cells
include ALDH1 expression, and Sca-1. There is a signiﬁcant
correlation between expression of ALDH1 and HER2 over-
expression [50].
The common signaling pathways that control stem cell
self-renewal in these pathways, such as Notch, Wnt, and
Hedgehog, are known to play a role in carcinogenesis [2,
41]. A growing body of evidence from a variety of solid
tumors suggests that the ﬁrst carcinogenic cell within a
tumor possesses stem cell properties, including self-renewal,
increased cell survival, limitless replicative potential, and the
ability to produce diﬀerentiating cells [51–60]. However, it is
unclear whether accumulation of mutations within a tumor
cell with stem cell properties or extrinsic factors originating
in the tumor microenvironment drive tumor progression
[61, 62]. Understanding niche signaling pathways under
normal conditions, and in response to inﬂammation and
stress response, is vital to understanding how they may go
awry in carcinogenesis.
The known link between inﬂammation and cancer may
involve the regulation of stem cell fate by inﬂammatory
cytokines [63]. IL-1, IL-6, and IL-8 are known to activate
Stat3/NF-κB pathways in tumor and stromal cells. Posi-
tive feedback loops are formed involving further cytokine
production which can drive cancer stem cell self-renewal
[63]. These networks can be nicely modeled using stochastic
reaction kinetics. Predictions from these models could be
used to guide therapy design.
Dysregulation of normal homeostatic processes in the
human hematopoietic stem cell niche may lead to enhanced
self-renewal and proliferation, enforced quiescence, and
resistance to chemotherapeutic agents. Leukemic stem cells
have been shown to inﬁltrate the normal HSC niche by
direct invasion or secretion of substances such as stem cell
factor [6]. Leukemic stem cells may also exhibit dysregulated
homingandengraftment,leadingtoalternativenicheforma-
tion [6]. Future mathematical models of leukemic stem cell
dynamics should take into account the stem cell niche.
Cytokine/Jak/Stat signaling has recently been shown to
mediateregenerationandresponsetostressintheDrosophila
midgut [45, 64]. Mathematical models of proliferation
and diﬀerentiation of Drosophila intestinal stem cells have
examined the dynamics of Wnt and Notch signaling [30],
but have not yet examined the feedback of Jak/Stat signaling
from the diﬀerentiated enterocytes to intestinal stem cells.
Mathematical models of the human intestinal stem cell niche
have shown that dysregulated colonic crypt dynamics cases
stem cell overpopulation and initiate colon cancer [36].
Symmetric division of cancer stem cells has been shown to
be a key mechanism of tumor growth to target in therapeutic
approaches [37].
In mammalian systems, MyD88 and RAS signaling have
been shown to lead to mouse and human cell transformation
[65].Thesesignalingpathwaysareknowntobeinvolvedwith
inﬂammation and also play a direct role in cell cycle control.
The link between inﬂammation and carcinogenesis needs to
be studied quantitatively.
Alterations in Wnt signaling contribute to excess pro-
liferation of mammary progenitor cells leading to cancer
[66]. Unregulated Notch signaling in the mouse mammary
gland leads to tumor formation. Increased expression of
Notch in ductal carcinoma is associated with shorter time
to recurrence [67]. Breast density is an important risk factor
for breast tumor development [68], suggesting a role of
the stem cell microenvironment in carcinogenesis. Growth
factors secreted by ﬁbroblasts inﬂuence mammary stem cell
behavior. Endothelial cell and adipocytes may also inﬂuence
stem cell behavior. CCL5 secretion by mesenchymal stem
cells inﬂuences stem cell self-renewal. Alterations in Notch
signaling are thought to play a role in breast cancer develop-
ment.6 Stem Cells International
Endothelial
cells
Myoepithelial
progenitor
progenitor
progenitor
Mammary
stem
cells
Bipotent
Stromal cells
Adipocytes
Luminal
Luminal
center
Myoepithelial
cells
cells
diﬀerentiated
luminal epithelial
(a)
MSC BPP
MEP MC
LP LC
ESC
Fibroblast
Mesenchymal
SCs
ALDH-1
HER2
Sca-1
Hh
Bmi-1
Wnt Notch4
GF
CCL5
Notch3
Notch
(b)
Figure 3: Model of the breast stem cell niche including structural elements (left panel) and mathematical model (right panel). Key
populations of the mammary stem cell niche include mammary stem cells (MSCs), mesenchymal stem cells, endothelial stem cells (ESCs),
bipotent progenitor (BPP), luminal progenitor (LP), myoepithelial progenitor (MEP), myoepithelial cells (MCs), luminal epithelial cells
(LCs), and stromal cells. Wnt, Notch, and Hedgehog (Hh) signaling play a role in MSC self-renewal. Regulatory signals from growth factors
(GFs) secreted by ﬁbroblasts and CCL signaling from mesenchymal stem cells also regulate MSC fate.
Combination of theory and experiment has shed light on
stromal-tumor interactions in the human breast [69]. In the
breast, ductal cells secrete TGF-beta and ﬁbroblasts secrete
EGF. During carcinogenesis, TGF-beta then transforms
ﬁbroblasts into myoﬁbroblasts, which in turn secrete higher
EGF. Mathematical modeling has shown that this feedback
system increases proliferation of tumor cells, and theoretical
results match experimental validation well.
Mathematical models have also shed light on the interac-
tions between the stem and nonstem compartments of solid
tumors and their eﬀects on the heterogeneous growth of
solid tumors. These models show that apoptosis of nonstem
cells paradoxically leads to tumor growth and progression
[70, 71].
Cancer cell plasticity is an important consideration in
the study cancer stem-like cells in oncology. The ﬁnding
that nonstem cells can dediﬀerentiate to a stem-like state
in mammary cell lines [72] has important implications
in deﬁning cancer stem-like cells and identifying therapies
to target them. Markov models have recently proven very
helpful in calculating rates of dediﬀerentiation of mammary
epithelial cells to stem-like cells [73]. Consideration of
microenvironmental signaling that regulates these transi-
tionswillgreatlyenhancethesemodelsandtheirpredictions.
5. SpatialConsiderations in Modeling
Stem Cell Regulation
Spindle orientation is well known to play a role in stem cell
fate [74]. Asymmetric division is regulated by maintaining
the stem cell orientation, and this is regulated by its spatial
relationship with the cells of the niche. Induction of brain
tumor growth has been demonstrated by altering stem-cell
asymmetric division in Drosophila melanogaster [41]. Loss
of cell polarity and cancer are tightly correlated [4]. In stem
cells, loss of polarity leads to impairment of asymmetric cellStem Cells International 7
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Figure 4: Stem cell polarity: homeostasis and dysregulation. Regulation of asymmetric division in the stem cell niche. The left panel
represents spatial regulation of normal homeostasis, while the right panel demonstrates the loss of this asymmetry during carcinogenesis.
division, altering cell fates, rendering daughter cells unable
to respond to the mechanisms that control proliferation.
Thetumorsuppressorp53regulatespolarityofself-renewing
divisions in mammary stem cells [75]. Figure 4 displays
regulation of stem cell asymmetric division under normal
homeostatic conditions and the loss of this regulation during
carcinogenesis. Labeling of template strands in stem cells
of small intestine crypts using tritiated thymidine reveals
selective retention of parental DNA strands and loss of
newly synthesized strands during stem cell division [76].
This mechanism provides the stem cell with protection from
DNA replication errors during asymmetric division. Loss
of asymmetric division may lead to loss of this protection
against chromosomal instability.
Mathematical models that allow for the inclusion of
spatial eﬀects are necessary in order to study this loss of
asymmetry in the stem cell and its relation to carcino-
genesis. Classic models of spatial eﬀects on development
in Drosophila have examined reaction diﬀusion equations
[38, 39]. While multiscale models are more recently being
used to study complex biologic systems and their genetic
regulation, most of the methods used assume a well-stirred
system and have not allowed for consideration of spatial
eﬀects until recently. Incorporating a spatial component
into stochastic simulation methods is an exciting frontier in
stochastic reaction kinetics [77, 78]. A stochastic reaction-
diﬀusion equation is used in place of the chemical master
equation and is sampled in the stochastic simulation. These
methods have been shown to be successful in modeling
spatial eﬀects in genetic regulatory networks [78].
6. Conclusions
Mathematical models have proven useful in characterizing
stem cell and progenitor cell population dynamics, and in
understanding the interacting components of the stem cell
niche. Identifying quantitative characteristics of the stem cell
microenvironment that are generalizable across tissues, as
well as those distinct to each system, will be necessary to
help deﬁne the emerging concept of the stem cell niche.
Modeling the components of the stem cell niche and their
interactions will advance our understanding of the tight
regulation of stem cell fate. In turn, it will allow us to predict
and validate responses to stress, inﬂammation, and carcino-
genesis. In addition to quantifying population distributions
and feedback networks, it will be necessary and informative
to incorporate spatial aspects that govern asymmetric versus
symmetric stem cell self-renewal. We expect that the combi-
nation of predictive modeling and experimental validation
will prove useful in our understanding of the regulatory
components of stem cell maintenance and the changes that
occur in response to treatments designed to target the stem
cell niche.
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